Inyx (IYXI) EPS (Basic): $-0.82 (TTM As of Sep. 2006)


What is Inyx EPS (Basic)?

Inyx IYXI -99.00% EPS (Basic) is $-0.82 as of Sep. 2006.

Inyx's basic earnings per share (Basic EPS) for the three months ended in Sep. 2006 was $-0.19. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Sep. 2006 was $-0.82.

Inyx's EPS (Diluted) for the three months ended in Sep. 2006 was $-0.19. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2006 was $-0.82.

Inyx's EPS without NRI for the three months ended in Sep. 2006 was $-0.19. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Sep. 2006 was -0.80.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.


Inyx  (OTCPK:IYXI) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Inyx EPS (Basic) Related Terms


Inyx EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Inyx's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Inyx EPS (Basic) Chart

Inyx Annual Data
Trend Dec02 Dec03 Dec04 Dec05
EPS (Basic)
-0.02 -0.59 -0.52 -0.78

Inyx Quarterly Data
Mar02 Jun02 Sep02 Dec02 Mar03 Jun03 Sep03 Dec03 Mar04 Jun04 Sep04 Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.12 -0.37 -0.06 -0.20 -0.19

Inyx EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Inyx's Basic EPS for the fiscal year that ended in Dec. 2005 is calculated as

Basic EPS (A: Dec. 2005 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-31.009-0)/39.774
=-0.78

Inyx's Basic EPS for the quarter that ended in Sep. 2006 is calculated as

Basic EPS (Q: Sep. 2006 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-9.743-0)/51.985
=-0.19

EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2006 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.82

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of $-0.82 mean?
Inyx (IYXI) has a EPS (Basic) of $-0.82 as of Sep. 2006. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Inyx and its competitors.
Is Inyx's EPS (Basic) too high?
Inyx's current EPS (Basic) is $-0.82.
How does Inyx's EPS (Basic) compare to NUVPF and ADMD?
Inyx's EPS (Basic) of $-0.82 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Drug Manufacturers company?
A good EPS (Basic) depends on the Drug Manufacturers industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Inyx and its competitors. Inyx's current EPS (Basic) is $-0.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inyx stock overvalued right now?
Inyx (IYXI) has a current EPS (Basic) of $-0.82. The current EPS (Basic) is $-0.82. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Inyx (IYXI), the current EPS (Basic) is $-0.82 as of Sep. 2006. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Inyx Business Description

Address 825 3rd Avenue, 40th Floor, New York, NY, USA, 10022
Inyx Inc is focused on the development, manufacture, and marketing of prescription and over-the-counter aerosol products and drug delivery technologies for the treatment of respiratory, allergy, cardiovascular and dermatological, and topical conditions.